The increasing interest in potent weight management has resulted in considerable research into groundbreaking treatments. Recently , Retatrutide, a combined -action hormone and glucagon-like peptide-1 (GLP-1) receptor agonist , has demonstrated encouraging results in patient trials, suggesting po